Co-Diagnostics CODX
NASDAQ CODX
$1.08 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Co-Diagnostics (CODX) Non-Current Deffered Revenue (2017 - 2018)

Analysis

Co-Diagnostics (CODX) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn -
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn -
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn -
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn -
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn -
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn -
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn -
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn -
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn -
10 Co-Diagnostics 4.65 Mn 4.65 Mn 120,828.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 126,066.00
Jun 30, 2018 135,762.00
Mar 31, 2018 145,458.00
Dec 31, 2017 183,546.00
Sep 30, 2017 186,144.00
Jun 30, 2017 188,742.00
API Access

Co-Diagnostics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CODX&period=max&api_key=YOUR_API_KEY